Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 133,334 shares at $80.13 ($10.7M) on 2019-05-16, disclosed to the SEC on 2019-05-20.
Open-market sale of $10.7M NBIX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.13 | 731 | $59K | 0.5% |
| 2 | $80.13 | 9,121 | $731K | 6.8% |
| 3 | $80.13 | 22,439 | $1.8M | 16.8% |
| 4 | $80.13 | 34,376 | $2.8M | 25.8% |
| 5 | $80.13 | 34,376 | $2.8M | 25.8% |
| 6 | $80.13 | 731 |
| $59K |
| 0.5% |
| 7 | $80.13 | 22,439 | $1.8M | 16.8% |
| 8 | $80.13 | 9,121 | $731K | 6.8% |
| Total | $80.13 avg | 133,334 | $10.7M | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |